ARTICLE | Company News
Bentley Pharma, Dong Sung Pharm. Co. Ltd. deal
May 2, 2005 7:00 AM UTC
The companies partnered to develop BNT's intranasal insulin in South Korea to treat diabetes. Dong Sung will fund Phase II and Phase III trials and be responsible for regulatory submissions. ...